54 results
6-K
EX-99.2
CANF
Can-Fite Biopharma Ltd
31 Aug 23
Report of Foreign Private Issuer
7:12am
measures its short-term investment at fair value. Short-term investments are classified within Level 1 as the valuation inputs are valuations based … accounted for the aforementioned warrants as freestanding instrument classified at part of the Company’s permanent equity in accordance with ASC-480 and ASC
6-K
EX-99.2
CANF
Can-Fite Biopharma Ltd
25 Aug 22
Report of Foreign Private Issuer
7:16am
, the FASB issued ASU No. 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The ASU … -classified written call options (such as warrants) by specifying the accounting for various modification scenarios. The ASU is effective for interim
6-K
EX-99.2
kia9g9w18 2j5hjz
26 Aug 21
Report of Foreign Private Issuer
7:28am
6-K
EX-99.1
0k1vu3qbqt0
30 Nov 20
Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
7:12am
6-K
EX-99.2
90slggeq8dj9limdg
27 Aug 20
Report of Foreign Private Issuer
7:10am
424B3
nz3o 160bpzbbt2xlq8w
1 Jun 20
Prospectus supplement
7:23am
6-K
EX-99.2
vdjz djnchuwtje95ib
1 Jun 20
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
unk3gw3uprv
1 Jun 20
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
nefl11mq2makrm3bu03
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
oirvri
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
jvpb00g8
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
bdrvrw4sx2ya5v
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
nzual1ax4oxndqg q4n
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
6-K
EX-99.1
21shxdd 1r3quvo
29 Nov 19
Can-Fite Reports Third Quarter 2019 Financial Results & Provides Clinical Update
7:15am